Sarah Thompson, PharmD, CDOE Director of Clinical Services, Coastal Medical.

Slides:

Advertisements

Similar presentations

5th Annual PBM Pharmacy Informatics Conference

Advertisements

Role of the Pharmacist in Collaborative Care for Mental Health and Addiction Treatment in Medically Underserved Appalachia Sarah T. Melton, PharmD,BCPP,CGP.

Transitional Care Post Discharge; Tracking and Documentation.

QIPS All Section Call Opiate use in the ED. Objectives Identify the key components of opiate contracts and principles of how to use them effectively.

Sublingual Buprenorphine and Pain

Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.

Using the Maine PMP to Improve Prescribing Practices for Potentially Addictive Prescription Medications Susan Payne, MPH, PhD Research Professor Institute.

VCU Chronic Nonmalignant Pain Management: An Online Curriculum Leanne M. Yanni, MD Creator & Editor VCU Medical Center November 16 th, 2007.

Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.

Overview and Workflow Considerations with RPMS Pharmacy 5/7 and the Electronic Health Record Brian Wren Pharm.D., BCPS Chief, Pharmacy Services W.W. Hastings.

March 2015 is. PHARMACISTS: TRUSTED CARE WHEN AND WHERE YOU NEED IT.

IHS Pharmacy Policies and Procedures

Chronic Pain Initiative CCNC and Project Lazarus: Chronic Pain and Community Initiative.

Richard Z Aramini, PharmD PGY-1 Pharmacy Practice Resident Bay Pines VA Healthcare Center.

Incorporating Best Practices through Practice Organization & EMRs in a Residency Practice Mathew Devine, D.O. Associate Medical Director Highland Family.

IHS EHR Indian Health Service Electronic Health Record Pharmacy CDR Jim Gemelas, R.Ph. Clinical Applications Coordinator.

April 15 th is not just the deadline for your taxes!!! Is your documentation complete for Pharmacist to Registered Technician Ratios? Policies.

For Pain or Not for Pain: Methadone Madness

Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.

Copyright © 2009 by The McGraw-Hill Companies, Inc. All Rights Reserved. McGraw-Hill Chapter 3 Electronic Health Records in the Physician Office Electronic.

Pain Management- Hydrocodone Lara Offenburger PA-C No Disclosures ©AAHCM.

Pharmacy Paperless Refill. Presenters : Angela Kihega, RHIT Oklahoma City Area HIM Consultant Amy Rubin, PharmD Oklahoma City Area Clinical Applications.

John Lipovsky, MPPM, AREM, PMM

BANNER AND CARE1ST POPULATION HEALTH MODEL Transitioning to a value based model focused on outcome measures driven by providers and engaged members.

Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.

TNSAM Addiction Medicine. Data source: Tennessee Department of Health, Office of Health Statistics, Death Statistical System. Overdose deaths were defined.

Pharmacist Medical Providers: Post-SB 5557 Update Don Downing Clinical Professor, UW School of Pharmacy

Safer Opiate Prescribing A population-based approach to opiate prescriptions in a small, urban family practice Katharine Barnard MD, Mary Flynn MD, Julie.

Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.

Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.

Collaborative Pilot Project: Connecting EMRs with the IL PMP to Improve Medication Safety IL Prescription Monitoring Program IHA’s Institute for Innovations.

A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.

ABC-MAP Act 191 of 2014 September 16, 2016 Pennsylvania’s Prescription Drug Monitoring Program (PA PDMP)

Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong

Wireless Access SSID: cwag2017

Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.

Objectives of behavioral health integration in the Family Care Center

Buprenorphine Agreement

Opioid Management in Primary Care Michael Parchman, MD, MPH

Choice – 6 Steps, 6 Actions, 6 Weeks

Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist

The opioid registry is here!

Medication-Assisted Therapy at Coleman Profession Services

Charlotte Crist, BS, RN-BC, CCM, CPHQ

Caldwell County Narcotic Initiative

Place name sticker or stamp with card

Be the Change. Do Something.

New York State Collaborative Care Medicaid Program

OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.

CHAPTER 4 Information Management in Pharmacy.

PMP Advisory Committee

The Six Building Blocks

Opioid Prescribing & Monitoring

Health Home Program Services

Complete a legally valid prescription.

Controlled substance compliance

Appropriate Opiate Prescribing: Managing Chronic Pain in a FQHC

Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.

Barbara Allison-Bryan, MD

Prescription Drug Monitoring Program

The first screen used is designed to document symptom pursuit and review the complications of anticoagulation therapy. In addition this screen is where.

The Research Question How and why do primary care physicians (PCPs) use medications including antipsychotics, as well as non-pharmacologic strategies,

Statewide Health Home Initiatives

Prescription Drug Monitoring Program

Essentials of Good Pain Care: A Team-Based Approach

Part II Objectives Describe how policies and procedures are used

Pain Management JEFFREY TAN HO, D.O.

Presentation transcript:

Sarah Thompson, PharmD, CDOE Director of Clinical Services, Coastal Medical

Background 2014 RI opiate overdose rates highest in nation Department of Health draft regulations Pain management is increasingly becoming a primary care issue

Defining the Population Patients who are prescribed an opiate for chronic pain management For greater than 28 consecutive days By a Coastal Medical Provider Verified that no other medical providers are also prescribing opiates

Patient Identification Data reports Refill requests Record Review Prescription Monitoring Program Urine Tox testing CSA signing Appointment with Pharmacist or Provider Documentation in record Monitoring Urine Tox results sent to PharmD MAs/Pharm Techs verify signed CSAs Practice Level Workflow Opiate Stewardship Approach Consensus from CPC to evaluate Coastal process Asked Pharmacy team to work with pilot practice Clinical Practices Committee Workflow evaluation Testing of CSA Piloted Pharmacy visits Pilot Practice EHR codes PMP access EHR templates Uniform controlled substance policy Development Needs Board Approval of policy Pharmacy and provider led visits Yearly Monitoring Practice wide rollout

Controlled Substance Agreement Risks, benefits and side effects of treatment Signs and symptoms of tolerance, physical dependence, and addiction Patient agrees to: Random urine tox screening Notify PCP if another provider prescribes opiate therapy, including ED Receive prescriptions at one pharmacy Follow office policy for refill requests Provide photo identification to pick up prescription

EHR Enhancements Problem list codes “CSA: Controlled Substance Agreement” “Controlled substance agreement terminated” Important for Coastal 365 clinic CSA signing template PMP review date Counseling language Adds problem list codes

CSA Template Structured date for signing Structured date for PMP review Counseling for use, risks, and benefits of controlled substances

CSA Termination Template Structured data fields for: Date of termination Reason for termination Problem list code indicating termination of CSA: Z92.89 Statement indicating the provider will no longer prescribe chronic controlled substances

Future Directions Annual monitoring of CSA renewals Monitoring provider sign up for PMP Patient population risk stratification Institute prescribing standards for top pain conditions

Sarah Thompson, PharmD, CDOE Director of Clinical Services, Coastal Medical